Belite Bio (BLTE) Return on Equity [ROE] (2023 - 2026)
Belite Bio's Return on Equity [ROE] came in at -9.78% for Q2 2026, up 15.58 percentage points from -25.36% a year earlier but down 1.52 percentage points from the prior quarter.
Powered by 
Analysis
Belite Bio (BLTE) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Belite Bio's Return on Equity [ROE] was -16.91%, up 13.93 percentage points from FY2024.
- Return on Equity [ROE] has increased in each of the last three years, with a three-year change of +80.36 percentage points (FY2022 to FY2025).
- Going back by year, Return on Equity [ROE] was -30.84% in FY2024 (+17.08 pp), -47.92% in FY2023 (+49.35 pp) and -97.27% in FY2022.
- The five-year range for quarterly Return on Equity [ROE] is -48.72% (Q1 2023) to -8.26% (Q1 2026).
- Year-over-year, Return on Equity [ROE] has increased for ten consecutive quarters, with an average year-over-year change of +11.03 percentage points over the last eight quarters.
- Over the past five years, the year-over-year gain in Return on Equity [ROE] ranged from 1.97 percentage points (Q2 2024) to 21.10 percentage points (Q1 2024).
- Business Quant data shows BLTE's Return on Equity [ROE] at -8.26% (Q1 2026), -9.97% (Q4 2025) and -24.56% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Belite Bio | 6.68 Bn | 6.68 Bn | - | -9.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.78% |
| Mar 31, 2026 | -8.26% |
| Dec 31, 2025 | -9.97% |
| Sep 30, 2025 | -24.56% |
| Jun 30, 2025 | -25.36% |
| Mar 31, 2025 | -21.30% |
| Dec 31, 2024 | -20.21% |
| Sep 30, 2024 | -29.04% |
| Jun 30, 2024 | -33.47% |
| Mar 31, 2024 | -27.62% |
| Dec 31, 2023 | -34.53% |
| Sep 30, 2023 | -45.20% |
| Jun 30, 2023 | -35.44% |
| Mar 31, 2023 | -48.72% |
API Access
Belite Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BLTE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BLTE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BLTE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();